Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
60.32
-0.04 (-0.07%)
Sep 1, 2026, 12:41 PM EDT - Market open
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, Ionis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $88. The average 1-year stock price forecast is 45.89% higher than the current stock price, while the lowest is $60 (-0.53%) and the highest is $115 (+90.65%).
Price Target: $88 (+45.89%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 12 | 12 | 10 | 10 |
| Buy | 6 | 8 | 9 | 8 | 9 | 9 |
| Hold | 6 | 5 | 5 | 4 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 24 | 26 | 24 | 23 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $83 → $93 | Buy | Maintains | $83 → $93 | +54.18% | Sep 1, 2026 |
| Barclays | Barclays | Buy Maintains $90 | Buy | Maintains | $90 | +49.20% | Sep 1, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $69 | Hold | Maintains | $69 | +14.39% | Aug 31, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 31, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $95 | Buy | Reiterates | $95 | +57.49% | Aug 31, 2026 |
Financial Forecast
Revenue This Year
913.39M
from 943.71M
Decreased by -3.21%
Revenue Next Year
1.40B
from 913.39M
Increased by 53.51%
EPS This Year
-2.72
from -1.54
EPS Next Year
-1.09
from -2.72
EPS and Forward PE are based on non-GAAP adjusted numbers.